Program Highlight – Playroom Improvements

A hospital can be a scary place for a child, especially for pediatric cancer patients. Recent studies have proven what Making Headway has known for decades: the hospital’s physical environment affects the patients’ experiences, emotional needs, and health outcomes.  Every child at the Hassenfeld Children’s Center is able to benefit from the enhanced playroom and activities supported by Making Headway. Through our programs, Making Headway has transformed the halls and the playroom into a fun, healthy place for children and families. On any given day, children of all ages and backgrounds can be found happily absorbed in arts and crafts activities, games, or munching on healthy, delicious snacks. Professional entertainers and child therapists are also part of the playroom team, helping the whole family feel comfortable, relaxed and welcome.

5th Annual Brian McCabe Drive for a Cure Golf Outing

There is the rare day that you can enjoy a guilt-free day off from work to go golfing. That’s because you could be part of the 5th Annual Brian McCabe Drive for a Cure Golf Outing, which raises money to support children with brain cancer. Enjoy a beautiful afternoon out on the links for a great cause. September 25th, 2017, Split Rock and Pelham Bay Gold Courses. It’s not too late to sign up, just visit http://makingheadway.org/mccabe/.

Research Highlight: Cutting Edge Program funded by Making Headway

Dr. Daniel Reinberg is one of the most respected and accomplished medical investigators in the country and Making Headway has agreed to fund his latest research project. This unique research project focuses on a devastating type of pediatric brain tumor known as Diffuse Intrinsic Pontine Gliomas (DIPGs). Despite recent advances in diagnosis and treatment, the majority of children diagnosed with DIPG die within 24 months of diagnosis. Through a grant by Making Headway, Dr. Reinberg and his team are studying specific  compounds that block the ability of certain proteins that bind to a specific epigenetic signature, known as dimethylation of histone H3 on lysine residue 36 (H3K36me2). It’s a lot more complicated than that, but in the end, these compounds are very promising therapeutics for the treatment of this deadly childhood malignancy.   Learn more at http://makingheadway.org/research.